{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:40:24Z","timestamp":1699404024138},"reference-count":6,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:p>In patients undergoing coronary bypass grafting, we noticed that low\u2010dose aspirin failed to inhibit platelet aggregation, potentially elevating the risk of thrombotic bypass occlusion. This \u201chigh on\u2010treatment platelet reactivity\u201d was reproducible <jats:italic>in vitro<\/jats:italic> and could be transferred with patient plasma or urine to aspirin\u2010sensitive donor platelets, suggesting a drug\/drug interaction. Loss of aspirin efficacy was associated with analgesia by dipyrone (metamizol) and initiated further study of the interaction between aspirin and other nonopioid analgesics.<\/jats:p>","DOI":"10.1002\/cpt.21","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T16:44:03Z","timestamp":1423673043000},"page":"131-134","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of Antiplatelet Effects of Aspirin by Nonopioid Analgesics"],"prefix":"10.1111","volume":"97","author":[{"given":"T","family":"Hohlfeld","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Pharmakologie und Klinische Pharmakologie Heinrich\u2010Heine\u2010Universit\u00e4t D\u00fcsseldorf D\u00fcsseldorf Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Schr\u00f6r","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pharmakologie und Klinische Pharmakologie Heinrich\u2010Heine\u2010Universit\u00e4t D\u00fcsseldorf D\u00fcsseldorf Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"e_1_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-07-0532"},{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000081770.51929.5A"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02800.x"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.039"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.09.032"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003199"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.21","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:28:18Z","timestamp":1699363698000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1002\/cpt.21"],"URL":"https:\/\/doi.org\/10.1002\/cpt.21","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}